Viewing Study NCT05175950


Ignite Creation Date: 2025-12-24 @ 4:56 PM
Ignite Modification Date: 2025-12-28 @ 6:36 AM
Study NCT ID: NCT05175950
Status: UNKNOWN
Last Update Posted: 2023-02-14
First Post: 2022-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)
Sponsor: Korea University Guro Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module